quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 29, 2026

Who in Big Tech Is Ready for Agentic AI?

View original at nasdaq.com
Who in Big Tech Is Ready for Agentic AI? In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rachel Warren discuss: Amazon goes after Perplexity's agents.Meta's scattered AI strategy.Oracle's earnings…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Amazon's entire flywheel is built on owning the entire commerce journey from first search to package delivery

    60% confidence
  • Oracle's debt of $135 billion is about two times sales and five times EBITDA, which is not unreasonable

    60% confidence
  • Instant and complete comparison shopping could be the killer app for consumers

    60% confidence
  • If you invested $1,000 in Netflix on December 17, 2004, you'd have $503,861 as of March 28, 2026

    60% confidence
  • Meta's next act isn't just smarter chatbots, it's a whole infrastructure for AI agents to interact and transact

    60% confidence
  • Until AI models are big enough to force the issue, retailers like Amazon have no incentive to give in to Perplexity

    60% confidence
  • The facts on the ground for Oracle right now are really good and the stock is reflecting that

    60% confidence
  • Meta has all the cash in the world and is using it to assemble the brightest minds they can

    60% confidence
  • If you invested $1,000 in Nvidia on April 15, 2005, you'd have $1,026,987 as of March 28, 2026

    60% confidence
  • Meta is struggling to develop what they need in house and have found that acquiring outside talent is the best move

    60% confidence
  • This is more of an admission that the AI strategy is pivoting toward autonomous agents

    60% confidence
  • Oracle is betting they can convert the significant backlog into high margin profits before interest on debt catches up

    60% confidence
  • The 10 best stocks for investors to buy now don't include Meta Platforms

    60% confidence
  • Meta doesn't know how to get customers to pay for what they're building outside of in-house improvements

    60% confidence
  • If Oracle can go from $60 billion revenue now to $90 billion in 2027, that's really good

    60% confidence
  • The status quo benefits Amazon and it makes sense to preserve it as long as possible

    60% confidence
  • A lot of Oracle's RPO customers may not know if they need all the capacity they've secured

    60% confidence
  • Oracle is seeing its highest growth in 15 years but it's coming at a staggering cost

    60% confidence
  • Oracle is essentially an AI construction company right now racing to plug in chips faster than the competition

    60% confidence
  • AI agents are tireless shoppers that won't be distracted by deals or browse sponsored results that fuel Amazon's advertising machine

    60% confidence
  • Alphabet has spent about $40 billion on AI related acquisitions

    60% confidence
  • Meta's desperate attempts to get users to use their AI are pretty pathetic right now

    60% confidence
  • Moltbook is essentially allowing people and bots to communicate with AI agents in natural language through chat apps

    60% confidence
  • When a shift happens, the incumbent usually isn't the beneficiary

    60% confidence
  • If third party AI becomes the primary shopping interface, Amazon's advertising mode could start to dry up

    60% confidence

Data points we hold from this source

Stock Advisor · sp500 comparison return179 percent
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,985
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,985 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Who in Big Tech Is Ready for Agentic AI? — Source | Via News | pt.VIA.NEWS